시장보고서

상품코드

1781928

감염증 진단 시장 : 제품 및 서비스별, 검사 유형별, 샘플 유형별, 질환 유형별, 기술별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Infectious Disease Diagnostic Market, By Product & Service, By Type of Testing, By Sample Type, By Disease Type, By Technology, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2025년 06월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 399 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

감염증 진단 시장 규모는 2024년에 229억 1,800만 달러에 달하며, 2024-2032년에 CAGR 8.2%로 확대

감염병 진단 시장 - 시장 역학

감염성 질환 발병률 증가

세계 감염병 발병률 증가는 감염병 진단 시장의 주요 촉진요인입니다. 인구 밀도 증가, 세계 여행, 기후 변화 등의 요인이 병원균의 급속한 확산에 기여하고 있습니다. 또한 항생제 내성 균주 및 신종 감염병의 출현으로 정확하고 신속한 진단 툴의 필요성이 증가하고 있습니다. 조기에 정확한 진단을 통해 적시에 치료할 수 있으며, 질병 전파를 줄이고 환자의 예후를 개선할 수 있습니다. 그 결과, 헬스케어 시스템은 첨단 진단 기술에 대한 투자를 늘리고 있으며, 이는 감염병 감지 및 관리 시장의 성장과 혁신에 박차를 가하고 있습니다.

감염성 질환 진단 시장 - 주요 인사이트

당사의 리서치 애널리스트에 따르면 세계 감염병 진단 시장은 2024-2032년 약 8.2%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다.

2023년 제품 및 서비스별로는 시약, 키트, 소모품 카테고리가 시장을 장악하고 있습니다.

기술별로는 중합효소 연쇄반응(PCR) 부문이 2023년 가장 높은 매출을 창출할 것으로 예측됩니다.

지역별로는 2023년 북미가 가장 높은 매출을 올린 지역으로 나타났습니다.

감염병 진단 시장 - 세분화 분석

세계 감염병 진단 시장은 제품 및 서비스, 최종사용자, 검사 유형, 샘플 유형, 질병 유형, 기술, 지역 등 7가지 범주로 분류됩니다.

감염병 진단 시장은 제품 및 서비스별로 시약-키트-소모품, 기기, 소프트웨어 서비스 등 세 가지로 분류됩니다. 시약, 키트, 소모품에는 진단 검사 수행에 필수적인 화학물질, 검사 키트, 재료가 포함됩니다. 장비란 PCR 장치, 면역측정분석기, 현미경 등 진단 절차를 수행하기 위해 사용되는 장치나 기계를 말합니다. 소프트웨어 및 서비스에는 데이터 관리 툴, 진단 소프트웨어, 검사 정확도를 높이고 검사실 워크플로우를 간소화하는 지원 서비스가 포함됩니다. 이 중 시약, 키트, 소모품은 실험실과 병원에서 일상적인 검사에 대한 반복적인 수요로 인해 시장을 지배하고 있습니다. 높은 소비율과 검사 정확도에서의 중요한 역할로 인해 이 부문은 감염성 질환 진단 시장의 주요 매출 촉진요인으로 작용하고 있습니다.

감염병 진단 시장은 기술별로 면역진단, 임상미생물학, 중합효소연쇄반응(PCR), 등온핵산증폭기술, DNA 시퀀싱 및 차세대 시퀀싱(NGS), DNA 마이크로어레이, 기타 신흥기술로 분류됩니다. 면역진단학에서는 감염병을 확인하기 위해 항원이나 항체를 검출하여 감염병을 확인합니다. 임상미생물학은 미생물의 배양과 동정에 중점을 둡니다. PCR이나 등온 핵산증폭은 병원균의 DNA나 RNA를 증폭하여 정확하게 검출하는 분자 기술입니다. DNA 시퀀싱과 NGS는 병원체 식별 및 내성 프로파일링을 위한 종합적인 유전자 정보를 제공하고, DNA 마이크로어레이는 대규모 유전자 발현 분석을 가능하게 합니다. 이 중 중합효소연쇄반응(PCR)은 높은 민감도, 특이성, 빠른 소요시간, 전 세계 임상 실험실에서 광범위하게 채택되어 정확한 감염성 질환 검출을 위해 선호되는 선택으로 시장을 독점하고 있습니다.

감염병 진단 시장 - 지역적 인사이트

감염병 진단 시장은 북미, 아시아태평양, 라틴아메리카, 유럽, 중동 및 아프리카에 분포되어 있습니다. 이 지역들은 비즈니스를 초래하는 국가를 기준으로 더 세분화됩니다.

북미는 첨단화된 의료 인프라, 높은 의료비, 첨단 진단 기술의 보급으로 인해 감염성 질환 진단 시장에서 지배적인 지역입니다. 특히 미국은 연구개발에 대한 막대한 투자, 강력한 규제 지원, 대형 진단의약품 기업의 존재로 시장을 선도하고 있습니다. 이 지역에서는 질병의 조기 발견에 대한 중요성, 감염성 질환 증가, 의료 종사자들의 인식이 높아짐에 따라 시장 성장을 더욱 촉진하고 있습니다. 또한 진단 능력을 향상시키기 위한 정부의 구상과 신속한 현장 검사에 대한 수요 증가도 북미가 이 시장에서 압도적인 위치를 차지하고 있는 요인으로 작용하고 있습니다.

아시아태평양은 인구 증가, 의료 접근성 향상, 감염병 부담 증가로 인해 감염성 질환 진단 의약품의 주요 시장 중 하나로 빠르게 성장하고 있습니다. 중국, 인도와 같은 국가들은 의료 인프라의 확대와 의료 서비스에 대한 정부 지출 증가로 수요를 견인하고 있습니다. 이 지역은 인식 증가, 진단 시설의 개선, 더 나은 의료 서비스를 원하는 중산층 증가 등의 혜택을 누리고 있습니다. 또한 결핵, 뎅기열, COVID-19와 같은 전염병의 발생은 강력한 진단 솔루션의 필요성을 강조하고 있으며, 아시아태평양은 이 부문에서 빠르게 성장하는 전략적으로 중요한 시장으로 부상하고 있습니다.

감염병 진단 시장 - 경쟁 구도

감염병 진단 시장은 Abbott, F. Hoffman-La Roche, Thermo Fisher Scientific, BioMerule 등 광범위한 제품 포트폴리오와 지속적인 기술 혁신으로 우위를 점하고 있는 대기업이 주도하고 있습니다. 이들 기업은 연구개발에 많은 투자를 통해 진단 정확도, 속도, 자동화를 강화하여 엄격한 규제 기준을 충족하고 있습니다. 경쟁 환경은 분자진단 및 현장 검사 기술에 주력하는 신생 기업에 의해 주도되고 있습니다. 전략적 인수 및 제휴는 각 기업이 지역적 입지와 기술 역량을 확장하고 궁극적으로 전 세계에서 감염성 질환의 발견과 환자 치료 결과를 개선하기 위해 일반적으로 이루어지고 있습니다.

서론
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 튀르키예
- 알제리
- 이집트
- 기타

제14장 주요 벤더 분석 - 감염증 진단 산업

경쟁 대시보드
기업 개요
- F. Hoffmann-La Roche Ltd.
- Abbott
- Biomerieux
- Siemens Healthineers Ag
- Danaher
- Thermo Fisher Scientific Inc.
- Hologic, Inc.
- Becton, Dickinson And Company
- Revvity
- Qiagen
- Seegene Inc.
- Quidelortho Corporation
- Grifols, SA
- Diasorin SPA
- Bio-Rad Laboratories, Inc.
- Sysmex Corporation
- 기타

제15장 애널리스트의 전방위 전망

KSA 25.08.08

REPORT HIGHLIGHT

Infectious Disease Diagnostic Market size was valued at USD 22,918 Million in 2024, expanding at a CAGR of 8.2% from 2024 to 2032.

Infectious Disease Diagnostic refers to the process and methods used to detect, identify, and confirm the presence of pathogens such as bacteria, viruses, fungi, or parasites that cause infectious diseases in humans or animals. This diagnostic process employs various techniques, including laboratory tests like culture, microscopy, molecular assays (e.g., PCR), antigen detection, and serology. Accurate and timely infectious disease diagnostics are crucial for appropriate treatment decisions, infection control, and epidemiological surveillance. These diagnostics help differentiate infectious agents, monitor disease progression, and guide public health interventions to prevent outbreaks and manage patient care effectively.

Infectious Disease Diagnostic Market- Market Dynamics

Growing Prevalence of Infectious Diseases

The increasing incidence of infectious diseases worldwide is a key driver for the infectious disease diagnostics market. Factors such as rising population density, global travel, and climate change contribute to the rapid spread of pathogens. Additionally, the emergence of antibiotic-resistant strains and novel infectious agents has intensified the need for accurate, rapid diagnostic tools. Early and precise diagnosis enables timely treatment, reducing disease transmission and improving patient outcomes. Consequently, healthcare systems are investing more in advanced diagnostic technologies, fueling market growth and innovation in infectious disease detection and management.

Infectious Disease Diagnostic Market- Key Insights

According to our research analyst, the global Infectious Disease Diagnostic Market is expected to develop at a CAGR of approximately 8.2% between 2024-2032.

Segmented by Product And Service in 2023, the Reagents, Kits, And Consumables category dominated the market.

Based on Technology, the Polymerase Chain Reaction (PCR) segment generated the most income in 2023.

On the basis of region, in 2023, North America was the region with the highest revenue.

Infectious Disease Diagnostic Market- Segmentation Analysis:

The global Infectious Disease Diagnostic Market is divided into Seven categories: Product & Service, End User, Type of Testing, Sample Type, Disease Type, Technology, and Region.

The infectious disease diagnostics market is segmented by product and service into three main categories: reagents, kits, and consumables; instruments; and software & services. Reagents, kits, and consumables include the essential chemicals, test kits, and materials required for conducting diagnostic tests. Instruments refer to the devices and machinery used to perform diagnostic procedures, such as PCR machines, immunoassay analyzers, and microscopes. Software & services encompass data management tools, diagnostic software, and support services that enhance test accuracy and streamline laboratory workflows. Among these segments, reagents, kits, and consumables dominate the market due to their recurring demand in laboratories and hospitals for routine testing. Their high consumption rate and critical role in test accuracy make this segment a primary revenue driver in the infectious disease diagnostics market.

The infectious disease diagnostics market is categorized by technology into several key segments: immunodiagnostics, clinical microbiology, polymerase chain reaction (PCR), isothermal nucleic acid amplification technology, DNA sequencing & next-generation sequencing (NGS), DNA microarray, and other emerging technologies. Immunodiagnostics involves detecting antigens or antibodies to identify infections. Clinical microbiology focuses on culturing and identifying microorganisms. PCR and isothermal nucleic acid amplification are molecular techniques amplifying pathogen DNA or RNA for precise detection. DNA sequencing and NGS provide comprehensive genetic information for pathogen identification and resistance profiling, while DNA microarrays enable large-scale gene expression analysis. Among these, polymerase chain reaction (PCR) dominates the market due to its high sensitivity, specificity, rapid turnaround time, and widespread adoption in clinical laboratories worldwide, making it the preferred choice for accurate infectious disease detection.

Infectious Disease Diagnostic Market- Geographical Insights

Geographically, the Infectious Disease Diagnostic Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America is a dominant region in the infectious disease diagnostics market, driven by advanced healthcare infrastructure, high healthcare expenditure, and widespread adoption of cutting-edge diagnostic technologies. The U.S., in particular, leads due to significant investments in research and development, strong regulatory support, and the presence of major diagnostic companies. The region's focus on early disease detection, rising prevalence of infectious diseases, and growing awareness among healthcare providers further fuel market growth. Additionally, government initiatives to improve diagnostic capabilities and the increasing demand for rapid point-of-care testing contribute to North America's commanding position in this market.

Asia Pacific is another key market for infectious disease diagnostics, experiencing rapid growth fueled by a large and growing population, increasing healthcare access, and rising infectious disease burden. Countries like China and India drive demand due to expanding healthcare infrastructure and increased government spending on healthcare services. The region benefits from rising awareness, improved diagnostic facilities, and a growing middle class seeking better healthcare. Additionally, the outbreak of infectious diseases such as tuberculosis, dengue, and COVID-19 has emphasized the need for robust diagnostic solutions, positioning Asia Pacific as a fast-growing and strategically important market in this sector.

Infectious Disease Diagnostic Market- Competitive Landscape:

The infectious disease diagnostic market is shaped by leading players such as Abbott, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., and bioMerieux, which dominate through extensive product portfolios and continuous innovation. These companies invest heavily in research and development to enhance diagnostic accuracy, speed, and automation, meeting stringent regulatory standards. The competitive environment is also driven by emerging firms focusing on molecular diagnostics and point-of-care testing technologies. Strategic acquisitions and collaborations are common as companies seek to expand their geographic presence and technological capabilities, ultimately improving infectious disease detection and patient outcomes worldwide.

Recent Developments:

In March 2025, Abbott launched a new rapid molecular test for respiratory infections that delivers results in under 30 minutes, enhancing point-of-care diagnostics.

In January 2024, Roche expanded its diagnostic testing portfolio with the introduction of a highly sensitive COVID-19 and flu multiplex assay, improving simultaneous detection of multiple pathogens.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

F. Hoffmann-La Roche Ltd.
Abbott
Biomerieux
Siemens Healthineers Ag
Danaher
Thermo Fisher Scientific Inc.
Hologic, Inc.
Becton, Dickinson And Company
Revvity
Qiagen
Seegene Inc.
Quidelortho Corporation
Grifols, S.A.
Diasorin S.P.A.
Bio-Rad Laboratories, Inc.
Sysmex Corporation
Others

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY PRODUCT & SERVICE - MARKET ANALYSIS, 2019 - 2032

Reagents, Kits, And Consumables
Instruments
Software & Services

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

Diagnostic Laboratories
Hospitals & Clinics
Academic Research Institutes
Other End Users

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY TYPE OF TESTING - MARKET ANALYSIS, 2019 - 2032

Laboratory Testing
POC Testing

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY DISEASE TYPE - MARKET ANALYSIS, 2019 - 2032

Hepatitis
Hepatitis B
Hepatitis C
Other Hepatitis Diseases
HIV
Hospital-Acquired Infections
Mosquito-Borne Diseases
HPV
Chlamydia Trachomatis
Neisseria Gonorrhea
Tuberculosis
Influenza
Syphilis
Covid-19
Other Infectious Diseases

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY TECHNOLOGY - MARKET ANALYSIS, 2019 - 2032

Immunodiagnostics
Clinical Microbiology
Polymerase Chain Reaction
Isothermal Nucleic Acid Amplification Technology
Dna Sequencing & Next-Generation Sequencing
Dna Microarray
Other Technologies

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY SAMPLE TYPE - MARKET ANALYSIS, 2019 - 2032

Blood, Serum, And Plasma
Urine
Other Sample Types

GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Infectious Disease Diagnostic Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Infectious Disease Diagnostic Market Snippet by Product & Service
- 2.1.2. Infectious Disease Diagnostic Market Snippet by Type of Testing
- 2.1.3. Infectious Disease Diagnostic Market Snippet by Sample Type
- 2.1.4. Infectious Disease Diagnostic Market Snippet by Disease Type
- 2.1.5. Infectious Disease Diagnostic Market Snippet by Technology
- 2.1.6. Infectious Disease Diagnostic Market Snippet by End User
- 2.1.7. Infectious Disease Diagnostic Market Snippet by Country
- 2.1.8. Infectious Disease Diagnostic Market Snippet by Region
2.2. Competitive Insights

3. Infectious Disease Diagnostic Key Market Trends

3.1. Infectious Disease Diagnostic Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Infectious Disease Diagnostic Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Infectious Disease Diagnostic Market Opportunities
3.4. Infectious Disease Diagnostic Market Future Trends

4. Infectious Disease Diagnostic Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Infectious Disease Diagnostic Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Infectious Disease Diagnostic Market Landscape

6.1. Infectious Disease Diagnostic Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Infectious Disease Diagnostic Market - By Product & Service

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product & Service, 2023 & 2032 (%)
- 7.1.2. Reagents, Kits, And Consumables
- 7.1.3. Instruments
- 7.1.4. Software & Services

8. Infectious Disease Diagnostic Market - By Type of Testing

8.1. Overview
- 8.1.1. Segment Share Analysis, By Type of Testing, 2023 & 2032 (%)
- 8.1.2. Laboratory Testing
- 8.1.3. POC Testing

9. Infectious Disease Diagnostic Market - By Sample Type

9.1. Overview
- 9.1.1. Segment Share Analysis, By Sample Type, 2023 & 2032 (%)
- 9.1.2. Blood, Serum, And Plasma
- 9.1.3. Urine
- 9.1.4. Other Sample Types

10. Infectious Disease Diagnostic Market - By Disease Type

10.1. Overview
- 10.1.1. Segment Share Analysis, By Disease Type, 2023 & 2032 (%)
- 10.1.2. Hepatitis
  - 10.1.2.1. Hepatitis B
  - 10.1.2.2. Hepatitis C
  - 10.1.2.3. Other Hepatitis Diseases
- 10.1.3. HIV
- 10.1.4. Hospital-Acquired Infections
- 10.1.5. Mosquito-Borne Diseases
- 10.1.6. HPV
- 10.1.7. Chlamydia Trachomatis
- 10.1.8. Neisseria Gonorrhea
- 10.1.9. Tuberculosis
- 10.1.10. Influenza
- 10.1.11. Syphilis
- 10.1.12. Covid-19
- 10.1.13. Other Infectious Diseases

11. Infectious Disease Diagnostic Market - By Technology

11.1. Overview
- 11.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
- 11.1.2. Immunodiagnostics
- 11.1.3. Clinical Microbiology
- 11.1.4. Polymerase Chain Reaction
- 11.1.5. Isothermal Nucleic Acid Amplification Technology
- 11.1.6. DNA Sequencing & Next-Generation Sequencing
- 11.1.7. DNA Microarray
- 11.1.8. Other Technologies

12. Infectious Disease Diagnostic Market - By End User

12.1. Overview
- 12.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
- 12.1.2. Diagnostic Laboratories
- 12.1.3. Hospitals & Clinics
- 12.1.4. Academic Research Institutes
- 12.1.5. Other End Users

13. Infectious Disease Diagnostic Market- By Geography

13.1. Introduction
- 13.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
13.2. North America
- 13.2.1. Overview
- 13.2.2. Infectious Disease Diagnostic Key Manufacturers in North America
- 13.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 13.2.4. North America Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
- 13.2.5. North America Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
- 13.2.6. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 13.2.7. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 13.2.8. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 13.2.9. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.2.10. U.S.
  - 13.2.10.1. Overview
  - 13.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.2.10.3. U.S. Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.2.10.4. U.S. Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.2.10.5. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.2.10.6. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.2.10.7. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.2.10.8. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.2.11. Canada
  - 13.2.11.1. Overview
  - 13.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.2.11.3. Canada Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.2.11.4. Canada Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.2.11.5. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.2.11.6. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.2.11.7. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.2.11.8. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.3. Europe
- 13.3.1. Overview
- 13.3.2. Infectious Disease Diagnostic Key Manufacturers in Europe
- 13.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 13.3.4. Europe Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
- 13.3.5. Europe Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
- 13.3.6. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 13.3.7. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 13.3.8. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 13.3.9. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.3.10. Germany
  - 13.3.10.1. Overview
  - 13.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.3.10.3. Germany Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.3.10.4. Germany Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.3.10.5. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.3.10.6. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.3.10.7. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.3.10.8. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.3.11. Italy
  - 13.3.11.1. Overview
  - 13.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.3.11.3. Italy Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.3.11.4. Italy Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.3.11.5. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.3.11.6. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.3.11.7. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.3.11.8. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.3.12. United Kingdom
  - 13.3.12.1. Overview
  - 13.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.3.12.3. United Kingdom Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.3.12.4. United Kingdom Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.3.12.5. United Kingdom Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.3.12.6. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.3.12.7. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.3.12.8. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.3.13. France
  - 13.3.13.1. Overview
  - 13.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.3.13.3. France Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.3.13.4. France Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.3.13.5. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.3.13.6. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.3.13.7. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.3.13.8. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.3.14. Russia
  - 13.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.3.14.2. Russia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.3.14.3. Russia Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.3.14.4. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.3.14.5. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.3.14.6. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.3.14.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.3.15. Netherlands
  - 13.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.3.15.2. Netherlands Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.3.15.3. Netherlands Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.3.15.4. Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.3.15.5. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.3.15.6. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.3.15.7. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.3.16. Sweden
  - 13.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.3.16.2. Sweden Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.3.16.3. Sweden Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.3.16.4. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.3.16.5. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.3.16.6. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.3.16.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.3.17. Poland
  - 13.3.17.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.3.17.2. Poland Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.3.17.3. Poland Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.3.17.4. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.3.17.5. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.3.17.6. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.3.18. Rest of Europe
  - 13.3.18.1. Overview
  - 13.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.3.18.3. Rest of the Europe Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.3.18.4. Rest of the Europe Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.3.18.5. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.3.18.6. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.3.18.7. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.3.18.8. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.4. Asia Pacific (APAC)
- 13.4.1. Overview
- 13.4.2. Infectious Disease Diagnostic Key Manufacturers in Asia Pacific
- 13.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 13.4.4. Asia Pacific Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
- 13.4.5. Asia Pacific Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
- 13.4.6. Asia Pacific Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 13.4.7. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 13.4.8. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 13.4.9. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.4.10. India
  - 13.4.10.1. Overview
  - 13.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.4.10.3. India Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.4.10.4. India Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.4.10.5. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.4.10.6. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.4.10.7. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.4.10.8. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.4.11. China
  - 13.4.11.1. Overview
  - 13.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.4.11.3. China Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.4.11.4. China Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.4.11.5. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.4.11.6. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.4.11.7. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.4.11.8. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.4.12. Japan
  - 13.4.12.1. Overview
  - 13.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.4.12.3. Japan Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.4.12.4. Japan Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.4.12.5. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.4.12.6. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.4.12.7. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.4.12.8. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.4.13. South Korea
  - 13.4.13.1. Overview
  - 13.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.4.13.3. South Korea Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.4.13.4. South Korea Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.4.13.5. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.4.13.6. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.4.13.7. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.4.13.8. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.4.14. Australia
  - 13.4.14.1. Overview
  - 13.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.4.14.3. Australia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.4.14.4. Australia Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.4.14.5. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.4.14.6. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.4.14.7. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.4.14.8. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.4.15. Thailand
  - 13.4.15.1. Overview
  - 13.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.4.15.3. Thailand Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.4.15.4. Thailand Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.4.15.5. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.4.15.6. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.4.15.7. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.4.15.8. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.4.16. Indonesia
  - 13.4.16.1. Overview
  - 13.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.4.16.3. Indonesia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.4.16.4. Indonesia Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.4.16.5. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.4.16.6. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.4.16.7. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.4.16.8. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.4.17. Philippines
  - 13.4.17.1. Overview
  - 13.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.4.17.3. Philippines Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.4.17.4. Philippines Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.4.17.5. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.4.17.6. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.4.17.7. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.4.17.8. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.4.18. Rest of APAC
  - 13.4.18.1. Overview
  - 13.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.4.18.3. Rest of APAC Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.4.18.4. Rest of APAC Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.4.18.5. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.4.18.6. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.4.18.7. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.4.18.8. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.5. Latin America
- 13.5.1. Overview
- 13.5.2. Infectious Disease Diagnostic Key Manufacturers in Latin America
- 13.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 13.5.4. Latin America Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
- 13.5.5. Latin America Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
- 13.5.6. Latin America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 13.5.7. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 13.5.8. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 13.5.9. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.5.10. Brazil
  - 13.5.10.1. Overview
  - 13.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.5.10.3. Brazil Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.5.10.4. Brazil Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.5.10.5. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.5.10.6. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.5.10.7. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.5.10.8. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.5.11. Mexico
  - 13.5.11.1. Overview
  - 13.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.5.11.3. Mexico Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.5.11.4. Mexico Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.5.11.5. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.5.11.6. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.5.11.7. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.5.11.8. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.5.12. Argentina
  - 13.5.12.1. Overview
  - 13.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.5.12.3. Argentina Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.5.12.4. Argentina Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.5.12.5. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.5.12.6. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.5.12.7. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.5.12.8. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.5.13. Colombia
  - 13.5.13.1. Overview
  - 13.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.5.13.3. Colombia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.5.13.4. Colombia Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.5.13.5. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.5.13.6. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.5.13.7. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.5.13.8. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.5.14. Rest of LATAM
  - 13.5.14.1. Overview
  - 13.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.5.14.3. Rest of LATAM Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.5.14.4. Rest of LATAM Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.5.14.5. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.5.14.6. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.5.14.7. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.5.14.8. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13.6. Middle East and Africa
- 13.6.1. Overview
- 13.6.2. Infectious Disease Diagnostic Key Manufacturers in Middle East and Africa
- 13.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 13.6.4. Middle East and Africa Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
- 13.6.5. Middle East and Africa Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
- 13.6.6. Middle East and Africa Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 13.6.7. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 13.6.8. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 13.6.9. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.6.10. Saudi Arabia
  - 13.6.10.1. Overview
  - 13.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.6.10.3. Saudi Arabia Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.6.10.4. Saudi Arabia Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.6.10.5. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.6.10.6. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.6.10.7. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.6.10.8. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.6.11. United Arab Emirates
  - 13.6.11.1. Overview
  - 13.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.6.11.3. United Arab Emirates Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.6.11.4. United Arab Emirates Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.6.11.5. United Arab Emirates Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.6.11.6. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.6.11.7. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.6.11.8. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.6.12. Israel
  - 13.6.12.1. Overview
  - 13.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.6.12.3. Israel Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.6.12.4. Israel Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.6.12.5. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.6.12.6. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.6.12.7. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.6.12.8. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.6.13. Turkey
  - 13.6.13.1. Overview
  - 13.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.6.13.3. Turkey Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.6.13.4. Turkey Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.6.13.5. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.6.13.6. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.6.13.7. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.6.13.8. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.6.14. Algeria
  - 13.6.14.1. Overview
  - 13.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.6.14.3. Algeria Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.6.14.4. Algeria Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.6.14.5. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.6.14.6. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.6.14.7. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.6.14.8. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.6.15. Egypt
  - 13.6.15.1. Overview
  - 13.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.6.15.3. Egypt Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.6.15.4. Egypt Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.6.15.5. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.6.15.6. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.6.15.7. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.6.15.8. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 13.6.16. Rest of MEA
  - 13.6.16.1. Overview
  - 13.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 13.6.16.3. Rest of MEA Market Size and Forecast, By Product & Service, 2019 - 2032 (US$ Million)
  - 13.6.16.4. Rest of MEA Market Size and Forecast, By Type of Testing, 2019 - 2032 (US$ Million)
  - 13.6.16.5. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 13.6.16.6. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 13.6.16.7. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 13.6.16.8. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

14. Key Vendor Analysis- Infectious Disease Diagnostic Industry

14.1. Competitive Dashboard
14.2. Company Profiles
- 14.2.1. F. Hoffmann-La Roche Ltd.
- 14.2.2. Abbott
- 14.2.3. Biomerieux
- 14.2.4. Siemens Healthineers Ag
- 14.2.5. Danaher
- 14.2.6. Thermo Fisher Scientific Inc.
- 14.2.7. Hologic, Inc.
- 14.2.8. Becton, Dickinson And Company
- 14.2.9. Revvity
- 14.2.10. Qiagen
- 14.2.11. Seegene Inc.
- 14.2.12. Quidelortho Corporation
- 14.2.13. Grifols, S.A.
- 14.2.14. Diasorin S.P.A.
- 14.2.15. Bio-Rad Laboratories, Inc.
- 14.2.16. Sysmex Corporation
- 14.2.17. Others

15. 360 Degree Analyst View

16. Appendix

16.1. Research Methodology
16.2. References
16.3. Abbreviations
16.4. Disclaimer
16.5. Contact Us